##### 



Exhibit 13
  SELECTED FINANCIAL DATA
 Income Statement Information (Amounts in thousands, except for per share data)
 FY 2007
    
    FY 2006
    
    FY 2005
    
    FY 2004
    
    FY 2003Net sales
    
    $122,963
    
    $108,413
    
    $92,965
    
    $79,606
    
    $65,864Gross profit
    
    
    74,940
    
    
    
    64,684
    
    
    
    54,890
    
    
    
    45,955
    
    
    
    38,383Operating income
    
    
    35,030
    
    
    
    26,894
    
    
    
    20,325
    
    
    
    14,956
    
    
    
    12,884Net earnings
    
    
    26,721
    
    
    
    18,333
    
    
    
    12,638
    
    
    
    9,366
    
    
    
    7,077Basic earnings per share
    
    $
    0.67
    
    
    $
    0.47
    
    
    $
    0.36
    
    
    $
    0.28
    
    
    $
    0.21Diluted earnings per share
    
    $
    0.66
    
    
    $
    0.46
    
    
    $
    0.35
    
    
    $
    0,27
    
    
    $
    0.21Cash dividends declared per share
    
    $
    0.40
    
    
    $
    0.28
    
    
    $
    0.20
    
    
    $
    0.17
    
    
    $
    0.15Book value per share
    
    $
    2.83
    
    
    $
    2.40
    
    
    $
    2.14
    
    
    $
    0.96
    
    
    $
    0.81
 Balance Sheet Information
 30-Sep-07
    
    30-Sep-06
    
    30-Sep-05
    
    30-Sep-04
    
    30-Sep-03Current assets
    
    $
    93,745
    
    
    $
    80,742
    
    
    $
    69,725
    
    
    $
    35,603
    
    
    $
    31,872Current liabilities
    
    
    17,067
    
    
    
    20,617
    
    
    
    19,791
    
    
    
    16,650
    
    
    
    15,330Total assets
    
    
    132,698
    
    
    
    120,528
    
    
    
    110,134
    
    
    
    68,814
    
    
    
    65,731Long-term debt obligations
    
    
    
    
    
    
    1,803
    
    
    
    2,684
    
    
    
    17,093
    
    
    
    21,505Shareholders equity
    
    
    112,948
    
    
    
    94,350
    
    
    
    83,333
    
    
    
    32,424
    
    
    
    26,795
 Forward Looking Statements
    
    The private securities Litigation Reform Act of 1995
provides a safe harbor from civil litigation for
forward-looking statements accompanied by meaningful cautionary
statements. Except for
historical information, this report contains forward-looking
statements which may be identified by
words such as estimates, anticipates, projects, plans, seeks,
may, will, expects, intends,
believes, should and similar expressions or the
negative versions thereof and which
also may be identified by their context. Such statements,
whether expressed or implied, are based
upon current expectations of the Company and speak only as of
the date made. The Company assumes no obligation to publicly update any
forward-looking statements. These statements
are subject to various risks, uncertainties and other factors that could
cause actual results to differ
materially, including, without limitation, the following:Meridians continued growth depends, in part, on its ability to
introduce into the marketplace enhancements of
existing products or new products that incorporate
technological advances, meet customer requirements and respond to
products developed by Meridians competition. While Meridian
has introduced a number of internally developed products, there can be no assurance that it will be
successful in the future in introducing such products on a timely basis. Ongoing consolidations of reference laboratories and formation of multi-hospital alliances may cause adverse changes to
pricing and distribution. Costs and difficulties in complying with laws and regulations administered by the United
States Food and Drug Administration can result in unanticipated expenses and delays and interruptions to the sale
of new and existing products. Changes in the relative strength or weakness of the U.S. dollar can change expected result. One
of Meridians main growth strategies is the acquisition of companies and product lines. There can be no assurance that
additional acquisitions will be consummated or that, if consummated, will be successful and
the acquired businesses successfully integrated into Meridians operations. In addition to the factors described
in the paragraph, Part 1, Item 1A Risk Factors of our Form 10-K contains a list of uncertainties and risks that may affect the financial performance of the Company.




---



##### 



CORPORATE PROFILE




---



##### 



Corporate Data
    
    Meridian Bioscience, Inc. and Subsidiaries
 Corporate Headquarters
    
    Annual Meeting3471 River Hills Drive
    
    The annual meeting of the shareholders will be held onCincinnati, Ohio 45244
    
    Tuesday, January 22, 2008 at 3:00 p.m. Eastern Time at the(513) 271-3700
    
    Holiday Inn Eastgate, 4501 Eastgate Boulevard, Cincinnati,OH 45245.Legal Counsel
    
    Directions to the Holiday Inn Eastgate can be found on ourKeating Muething & Klekamp PLL
    
    website: www.meridianbioscience.comCincinnati, OhioIndependent Public AccountantsGrant Thornton LLPCincinnati, OhioTransfer Agent, Registrar and DividendReinvestment AdministrationShareholders requiring a change of name, address or ownership
of stock, as well as information about shareholder records, lost or
stolen certificates, dividend checks, dividend direct deposit, and
dividend reinvestment should contact: Computershare Investor
Services LLC, P. O. Box 43078, Providence, RI 02940-3078;
(888) 294-8217 or (312) 601-4332: e-mail web.queries@com-
putershare.com; or submit your inquiries online through www.computershare.com/contactus.
    Years Ended September 30,
    
    2007
    
    2006Quarter ended:
    
    High
    
    Low
    
    High
    
    LowDecember 31
    
    
    17.160
    
    
    
    13.840
    
    
    
    15.340
    
    
    
    11.840March 31
    
    
    19.950
    
    
    
    16.250
    
    
    
    18.490
    
    
    
    13.410June 30
    
    
    22.470
    
    
    
    18.390
    
    
    
    18.670
    
    
    
    14.310September 30
    
    
    31.200
    
    
    
    21.300
    
    
    
    16.890
    
    
    
    12.830




---



##### 



PERFORMANCE GRAPH
  COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
 
 
 *
    
    $100 invested on 9/30/02 in stock or index-including reinvestment of dividends.
Fiscal year ending September 30.